CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial

Satimai Aniwan

Clin Endosc 2022;55(2):210-212. Published online 2022 March 14 DOI: https://doi.org/10.5946/ce.2022.063

Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial

Satimai Aniwan

Clinical Endoscopy. 2022;55(2):210-212

Link1

Link2 Link3

P.11.9: Mucosal and Transmural Healing During Anti-Tnf Therapy. Is Fecal Calprotectin a Marker of Therapeutic Response?

L. Ceccarelli, L. Bertani, N. De Bortoli, E. Albano, G. Laino, G. Tapete, A. Ricchiuti, M. Bellini, S. Marchi, F. Costa

Digestive and Liver Disease. 2017;49:e205-e206

Link1 Link2

Fecal Calprotectin Assay at an Early Stage of Treatment Can Be Used as a Surrogate Marker to Predict Clinical Remission and Mucosal Healing in Pediatric Crohn’s Disease

Yeoun Joo Lee, Jae Hong Park

Pediatric Gastroenterology, Hepatology & Nutrition. 2022;25(5):396

Link1 Link2 Link3

Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis

Sayaka Yamaguchi, Yoshiaki Takeuchi, Katsuhito Arai, Katsuyuki Fukuda, Yuichiro Kuroki, Kunio Asonuma, Hiroshi Takahashi, Masayuki Saruta, Hitoshi Yoshida

Journal of Gastroenterology and Hepatology. 2015;31(1):93-98

Link1 Link2 Link3

OC3.03.8 IS FECAL CALPROTECTIN A MARKER FOR MUCOSAL HEALING DURING INFLIXIMAB THERAPY?

V. D'Angelo, F. Morace, G. Amalfi, G. Caravelli, M. Di Pierro, C. Farinato, M. Schettino, G. Vespere, M. Rea, S. Monastra

Digestive and Liver Disease. 2008;40:S44-S45

Link1 Link2

Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial

Hyeong Ho Jo, Eun Young Kim, Jin Tae Jung, Joong Goo Kwon, Eun Soo Kim, Hyun Seok Lee, Yoo Jin Lee, Kyeong Ok Kim, Byung Ik Jang,

Clinical Endoscopy. 2022;55(2):256-262

Link1

Link2 Link3

Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis

Vendel Kristensen, Arne Røseth, Tahir Ahmad, Viggo Skar, Bjørn Moum

Gastroenterology Research and Practice. 2017;2017:1-5

Link1

Link2 Link3

Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis

Fang Chen, Yue Hu, Yi-Hong Fan, Bin Lv

Frontiers in Medicine. 2021;8:

Link1

Tu1961 Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease

Toshihiro Inokuchi, Jun Kato, Sakiko Hiraoka, Shiho Takashima, Daisuke Takei, Asuka Nakarai, Yuusaku Sugihara, Masahiro Takahara, Keita Harada, Seiji Kawano, Hiroyuki Okada

Gastroenterology. 2016;150(4):S991

Link1 Link2

Sa1049 Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Versus Fecal Immunochemical Test

Shiho Takashima, Jun Kato, Sakiko Hiraoka, Asuka Nakarai, Daisuke Takei, Toshihiro Inokuchi, Yuusaku Sugihara, Masahiro Takahara, Keita Harada, Hiroyuki Okada, Kazuhide Yamamoto

Gastroenterology. 2015;148(4):S-207

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Endosc has participated in CrossRef Text and Data Mining service since March 1, 2015.